nodes	percent_of_prediction	percent_of_DWPC	metapath
Rabeprazole—CYP1A1—kidney cancer	0.274	1	CbGaD
Rabeprazole—ABCG2—Pazopanib—kidney cancer	0.0399	0.0849	CbGbCtD
Rabeprazole—ABCG2—Dactinomycin—kidney cancer	0.0365	0.0777	CbGbCtD
Rabeprazole—ABCG2—Erlotinib—kidney cancer	0.0285	0.0606	CbGbCtD
Rabeprazole—CYP1A1—Erlotinib—kidney cancer	0.0263	0.0559	CbGbCtD
Rabeprazole—ABCG2—Paclitaxel—kidney cancer	0.0261	0.0555	CbGbCtD
Rabeprazole—CYP2D6—Temsirolimus—kidney cancer	0.0258	0.0549	CbGbCtD
Rabeprazole—CYP3A4—Everolimus—kidney cancer	0.0243	0.0517	CbGbCtD
Rabeprazole—ABCG2—Sorafenib—kidney cancer	0.0231	0.0493	CbGbCtD
Rabeprazole—ABCG2—Vincristine—kidney cancer	0.0225	0.0478	CbGbCtD
Rabeprazole—ABCG2—Sunitinib—kidney cancer	0.0188	0.0399	CbGbCtD
Rabeprazole—CYP1A2—Pazopanib—kidney cancer	0.0164	0.035	CbGbCtD
Rabeprazole—CYP3A4—Temsirolimus—kidney cancer	0.0164	0.0349	CbGbCtD
Rabeprazole—CYP2C9—Capecitabine—kidney cancer	0.0155	0.0329	CbGbCtD
Rabeprazole—ABCG2—Doxorubicin—kidney cancer	0.014	0.0299	CbGbCtD
Rabeprazole—CYP2D6—Pazopanib—kidney cancer	0.0136	0.0288	CbGbCtD
Rabeprazole—CYP1A2—Erlotinib—kidney cancer	0.0117	0.025	CbGbCtD
Rabeprazole—CYP2C19—Sorafenib—kidney cancer	0.0103	0.022	CbGbCtD
Rabeprazole—CYP2C9—Paclitaxel—kidney cancer	0.00968	0.0206	CbGbCtD
Rabeprazole—CYP2D6—Erlotinib—kidney cancer	0.00967	0.0206	CbGbCtD
Rabeprazole—CYP1A2—Sorafenib—kidney cancer	0.00954	0.0203	CbGbCtD
Rabeprazole—CYP3A4—Pazopanib—kidney cancer	0.00862	0.0183	CbGbCtD
Rabeprazole—CYP2C9—Sorafenib—kidney cancer	0.0086	0.0183	CbGbCtD
Rabeprazole—CYP2D6—Sorafenib—kidney cancer	0.00786	0.0167	CbGbCtD
Rabeprazole—CYP2D6—Vinblastine—kidney cancer	0.00776	0.0165	CbGbCtD
Rabeprazole—CYP3A4—Erlotinib—kidney cancer	0.00615	0.0131	CbGbCtD
Rabeprazole—CYP3A4—Paclitaxel—kidney cancer	0.00563	0.012	CbGbCtD
Rabeprazole—CYP3A4—Sorafenib—kidney cancer	0.005	0.0106	CbGbCtD
Rabeprazole—CYP3A4—Vinblastine—kidney cancer	0.00494	0.0105	CbGbCtD
Rabeprazole—CYP3A4—Vincristine—kidney cancer	0.00485	0.0103	CbGbCtD
Rabeprazole—CYP2D6—Doxorubicin—kidney cancer	0.00477	0.0102	CbGbCtD
Rabeprazole—CYP3A4—Sunitinib—kidney cancer	0.00405	0.00862	CbGbCtD
Rabeprazole—CYP3A4—Doxorubicin—kidney cancer	0.00303	0.00646	CbGbCtD
Rabeprazole—CYP2C19—urine—kidney cancer	0.00184	0.149	CbGeAlD
Rabeprazole—CYP1A2—urine—kidney cancer	0.0015	0.122	CbGeAlD
Rabeprazole—CYP2C9—urine—kidney cancer	0.00142	0.116	CbGeAlD
Rabeprazole—ATP4A—renal system—kidney cancer	0.00129	0.105	CbGeAlD
Rabeprazole—ATP4A—kidney—kidney cancer	0.00124	0.101	CbGeAlD
Rabeprazole—CYP3A4—urine—kidney cancer	0.00109	0.0883	CbGeAlD
Rabeprazole—CYP2D6—urine—kidney cancer	0.00107	0.0868	CbGeAlD
Rabeprazole—Omeprazole—CYP1A1—kidney cancer	0.000585	0.279	CrCbGaD
Rabeprazole—Lansoprazole—CYP1A1—kidney cancer	0.000535	0.255	CrCbGaD
Rabeprazole—ABCG2—nephron tubule—kidney cancer	0.00042	0.0341	CbGeAlD
Rabeprazole—Pantoprazole—ABCB1—kidney cancer	0.000381	0.182	CrCbGaD
Rabeprazole—CYP1A2—renal system—kidney cancer	0.000367	0.0298	CbGeAlD
Rabeprazole—CYP1A1—renal system—kidney cancer	0.000362	0.0294	CbGeAlD
Rabeprazole—CYP1A1—kidney—kidney cancer	0.00035	0.0284	CbGeAlD
Rabeprazole—CYP1A1—cardiac atrium—kidney cancer	0.000324	0.0264	CbGeAlD
Rabeprazole—Omeprazole—ABCB1—kidney cancer	0.000311	0.148	CrCbGaD
Rabeprazole—Lansoprazole—ABCB1—kidney cancer	0.000284	0.136	CrCbGaD
Rabeprazole—CYP3A4—renal system—kidney cancer	0.000266	0.0216	CbGeAlD
Rabeprazole—CYP2D6—renal system—kidney cancer	0.000261	0.0212	CbGeAlD
Rabeprazole—CYP3A4—kidney—kidney cancer	0.000257	0.0209	CbGeAlD
Rabeprazole—CYP2D6—kidney—kidney cancer	0.000253	0.0205	CbGeAlD
Rabeprazole—Myalgia—Paclitaxel—kidney cancer	5.8e-05	0.00029	CcSEcCtD
Rabeprazole—Anxiety—Paclitaxel—kidney cancer	5.78e-05	0.000289	CcSEcCtD
Rabeprazole—Face oedema—Doxorubicin—kidney cancer	5.78e-05	0.000288	CcSEcCtD
Rabeprazole—Decreased appetite—Gemcitabine—kidney cancer	5.77e-05	0.000288	CcSEcCtD
Rabeprazole—Hypersensitivity—Dactinomycin—kidney cancer	5.77e-05	0.000288	CcSEcCtD
Rabeprazole—Chills—Capecitabine—kidney cancer	5.76e-05	0.000288	CcSEcCtD
Rabeprazole—Arrhythmia—Capecitabine—kidney cancer	5.74e-05	0.000286	CcSEcCtD
Rabeprazole—Discomfort—Paclitaxel—kidney cancer	5.73e-05	0.000286	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Vincristine—kidney cancer	5.72e-05	0.000286	CcSEcCtD
Rabeprazole—Dizziness—Sorafenib—kidney cancer	5.69e-05	0.000284	CcSEcCtD
Rabeprazole—Constipation—Gemcitabine—kidney cancer	5.68e-05	0.000284	CcSEcCtD
Rabeprazole—Pain—Gemcitabine—kidney cancer	5.68e-05	0.000284	CcSEcCtD
Rabeprazole—Nausea—Erlotinib—kidney cancer	5.68e-05	0.000284	CcSEcCtD
Rabeprazole—Alopecia—Capecitabine—kidney cancer	5.67e-05	0.000283	CcSEcCtD
Rabeprazole—Dry mouth—Paclitaxel—kidney cancer	5.67e-05	0.000283	CcSEcCtD
Rabeprazole—Diarrhoea—Sunitinib—kidney cancer	5.66e-05	0.000283	CcSEcCtD
Rabeprazole—Asthenia—Dactinomycin—kidney cancer	5.62e-05	0.000281	CcSEcCtD
Rabeprazole—Confusional state—Paclitaxel—kidney cancer	5.6e-05	0.00028	CcSEcCtD
Rabeprazole—Erythema—Capecitabine—kidney cancer	5.59e-05	0.000279	CcSEcCtD
Rabeprazole—Malnutrition—Capecitabine—kidney cancer	5.59e-05	0.000279	CcSEcCtD
Rabeprazole—Dehydration—Doxorubicin—kidney cancer	5.56e-05	0.000278	CcSEcCtD
Rabeprazole—Oedema—Paclitaxel—kidney cancer	5.56e-05	0.000278	CcSEcCtD
Rabeprazole—Anaphylactic shock—Paclitaxel—kidney cancer	5.56e-05	0.000278	CcSEcCtD
Rabeprazole—Body temperature increased—Vincristine—kidney cancer	5.53e-05	0.000276	CcSEcCtD
Rabeprazole—Abdominal pain—Vincristine—kidney cancer	5.53e-05	0.000276	CcSEcCtD
Rabeprazole—Liver function test abnormal—Doxorubicin—kidney cancer	5.52e-05	0.000276	CcSEcCtD
Rabeprazole—Flatulence—Capecitabine—kidney cancer	5.51e-05	0.000275	CcSEcCtD
Rabeprazole—Dry skin—Doxorubicin—kidney cancer	5.48e-05	0.000274	CcSEcCtD
Rabeprazole—Dysgeusia—Capecitabine—kidney cancer	5.47e-05	0.000273	CcSEcCtD
Rabeprazole—Dizziness—Sunitinib—kidney cancer	5.47e-05	0.000273	CcSEcCtD
Rabeprazole—Feeling abnormal—Gemcitabine—kidney cancer	5.47e-05	0.000273	CcSEcCtD
Rabeprazole—Shock—Paclitaxel—kidney cancer	5.47e-05	0.000273	CcSEcCtD
Rabeprazole—Vomiting—Sorafenib—kidney cancer	5.47e-05	0.000273	CcSEcCtD
Rabeprazole—Abdominal pain upper—Doxorubicin—kidney cancer	5.46e-05	0.000273	CcSEcCtD
Rabeprazole—Hypokalaemia—Doxorubicin—kidney cancer	5.44e-05	0.000272	CcSEcCtD
Rabeprazole—Thrombocytopenia—Paclitaxel—kidney cancer	5.44e-05	0.000272	CcSEcCtD
Rabeprazole—Tachycardia—Paclitaxel—kidney cancer	5.42e-05	0.000271	CcSEcCtD
Rabeprazole—Rash—Sorafenib—kidney cancer	5.42e-05	0.000271	CcSEcCtD
Rabeprazole—Dermatitis—Sorafenib—kidney cancer	5.42e-05	0.000271	CcSEcCtD
Rabeprazole—Back pain—Capecitabine—kidney cancer	5.41e-05	0.00027	CcSEcCtD
Rabeprazole—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	5.39e-05	0.000269	CcSEcCtD
Rabeprazole—Headache—Sorafenib—kidney cancer	5.39e-05	0.000269	CcSEcCtD
Rabeprazole—Muscle spasms—Capecitabine—kidney cancer	5.37e-05	0.000268	CcSEcCtD
Rabeprazole—Hyperhidrosis—Paclitaxel—kidney cancer	5.37e-05	0.000268	CcSEcCtD
Rabeprazole—Diarrhoea—Dactinomycin—kidney cancer	5.36e-05	0.000268	CcSEcCtD
Rabeprazole—Anorexia—Paclitaxel—kidney cancer	5.3e-05	0.000265	CcSEcCtD
Rabeprazole—Gastritis—Doxorubicin—kidney cancer	5.29e-05	0.000264	CcSEcCtD
Rabeprazole—Alanine aminotransferase increased—Doxorubicin—kidney cancer	5.28e-05	0.000264	CcSEcCtD
Rabeprazole—Vision blurred—Capecitabine—kidney cancer	5.27e-05	0.000263	CcSEcCtD
Rabeprazole—Vomiting—Sunitinib—kidney cancer	5.26e-05	0.000263	CcSEcCtD
Rabeprazole—Body temperature increased—Gemcitabine—kidney cancer	5.25e-05	0.000262	CcSEcCtD
Rabeprazole—Tremor—Capecitabine—kidney cancer	5.24e-05	0.000262	CcSEcCtD
Rabeprazole—Rash—Sunitinib—kidney cancer	5.22e-05	0.000261	CcSEcCtD
Rabeprazole—Dermatitis—Sunitinib—kidney cancer	5.21e-05	0.00026	CcSEcCtD
Rabeprazole—Abdominal distension—Doxorubicin—kidney cancer	5.2e-05	0.00026	CcSEcCtD
Rabeprazole—Hypotension—Paclitaxel—kidney cancer	5.19e-05	0.000259	CcSEcCtD
Rabeprazole—Ill-defined disorder—Capecitabine—kidney cancer	5.19e-05	0.000259	CcSEcCtD
Rabeprazole—Headache—Sunitinib—kidney cancer	5.18e-05	0.000259	CcSEcCtD
Rabeprazole—Asthma—Doxorubicin—kidney cancer	5.17e-05	0.000258	CcSEcCtD
Rabeprazole—Dysphagia—Doxorubicin—kidney cancer	5.17e-05	0.000258	CcSEcCtD
Rabeprazole—Anaemia—Capecitabine—kidney cancer	5.17e-05	0.000258	CcSEcCtD
Rabeprazole—Hypersensitivity—Vincristine—kidney cancer	5.16e-05	0.000258	CcSEcCtD
Rabeprazole—Nausea—Sorafenib—kidney cancer	5.11e-05	0.000255	CcSEcCtD
Rabeprazole—Pancreatitis—Doxorubicin—kidney cancer	5.07e-05	0.000253	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.06e-05	0.000253	CcSEcCtD
Rabeprazole—Malaise—Capecitabine—kidney cancer	5.04e-05	0.000252	CcSEcCtD
Rabeprazole—Angina pectoris—Doxorubicin—kidney cancer	5.04e-05	0.000252	CcSEcCtD
Rabeprazole—Insomnia—Paclitaxel—kidney cancer	5.03e-05	0.000251	CcSEcCtD
Rabeprazole—Vertigo—Capecitabine—kidney cancer	5.02e-05	0.000251	CcSEcCtD
Rabeprazole—Asthenia—Vincristine—kidney cancer	5.02e-05	0.000251	CcSEcCtD
Rabeprazole—Syncope—Capecitabine—kidney cancer	5.01e-05	0.00025	CcSEcCtD
Rabeprazole—Leukopenia—Capecitabine—kidney cancer	5e-05	0.00025	CcSEcCtD
Rabeprazole—Paraesthesia—Paclitaxel—kidney cancer	4.99e-05	0.000249	CcSEcCtD
Rabeprazole—Vomiting—Dactinomycin—kidney cancer	4.98e-05	0.000249	CcSEcCtD
Rabeprazole—Bronchitis—Doxorubicin—kidney cancer	4.97e-05	0.000248	CcSEcCtD
Rabeprazole—Dyspnoea—Paclitaxel—kidney cancer	4.96e-05	0.000248	CcSEcCtD
Rabeprazole—Somnolence—Paclitaxel—kidney cancer	4.94e-05	0.000247	CcSEcCtD
Rabeprazole—Palpitations—Capecitabine—kidney cancer	4.94e-05	0.000247	CcSEcCtD
Rabeprazole—Rash—Dactinomycin—kidney cancer	4.94e-05	0.000247	CcSEcCtD
Rabeprazole—Nausea—Sunitinib—kidney cancer	4.91e-05	0.000245	CcSEcCtD
Rabeprazole—Loss of consciousness—Capecitabine—kidney cancer	4.91e-05	0.000245	CcSEcCtD
Rabeprazole—Pancytopenia—Doxorubicin—kidney cancer	4.91e-05	0.000245	CcSEcCtD
Rabeprazole—Dyspepsia—Paclitaxel—kidney cancer	4.89e-05	0.000244	CcSEcCtD
Rabeprazole—Cough—Capecitabine—kidney cancer	4.88e-05	0.000244	CcSEcCtD
Rabeprazole—Dysuria—Doxorubicin—kidney cancer	4.83e-05	0.000241	CcSEcCtD
Rabeprazole—Neutropenia—Doxorubicin—kidney cancer	4.83e-05	0.000241	CcSEcCtD
Rabeprazole—Decreased appetite—Paclitaxel—kidney cancer	4.83e-05	0.000241	CcSEcCtD
Rabeprazole—Hypertension—Capecitabine—kidney cancer	4.83e-05	0.000241	CcSEcCtD
Rabeprazole—Diarrhoea—Vincristine—kidney cancer	4.79e-05	0.000239	CcSEcCtD
Rabeprazole—Pollakiuria—Doxorubicin—kidney cancer	4.78e-05	0.000239	CcSEcCtD
Rabeprazole—Asthenia—Gemcitabine—kidney cancer	4.76e-05	0.000238	CcSEcCtD
Rabeprazole—Myalgia—Capecitabine—kidney cancer	4.76e-05	0.000238	CcSEcCtD
Rabeprazole—Chest pain—Capecitabine—kidney cancer	4.76e-05	0.000238	CcSEcCtD
Rabeprazole—Arthralgia—Capecitabine—kidney cancer	4.76e-05	0.000238	CcSEcCtD
Rabeprazole—Pain—Paclitaxel—kidney cancer	4.75e-05	0.000237	CcSEcCtD
Rabeprazole—Constipation—Paclitaxel—kidney cancer	4.75e-05	0.000237	CcSEcCtD
Rabeprazole—Anxiety—Capecitabine—kidney cancer	4.74e-05	0.000237	CcSEcCtD
Rabeprazole—Photosensitivity reaction—Doxorubicin—kidney cancer	4.72e-05	0.000236	CcSEcCtD
Rabeprazole—Weight increased—Doxorubicin—kidney cancer	4.71e-05	0.000235	CcSEcCtD
Rabeprazole—Discomfort—Capecitabine—kidney cancer	4.7e-05	0.000235	CcSEcCtD
Rabeprazole—Pruritus—Gemcitabine—kidney cancer	4.7e-05	0.000235	CcSEcCtD
Rabeprazole—Weight decreased—Doxorubicin—kidney cancer	4.68e-05	0.000234	CcSEcCtD
Rabeprazole—Hyperglycaemia—Doxorubicin—kidney cancer	4.66e-05	0.000233	CcSEcCtD
Rabeprazole—Dry mouth—Capecitabine—kidney cancer	4.65e-05	0.000232	CcSEcCtD
Rabeprazole—Nausea—Dactinomycin—kidney cancer	4.65e-05	0.000232	CcSEcCtD
Rabeprazole—Pneumonia—Doxorubicin—kidney cancer	4.64e-05	0.000232	CcSEcCtD
Rabeprazole—Dizziness—Vincristine—kidney cancer	4.63e-05	0.000231	CcSEcCtD
Rabeprazole—Confusional state—Capecitabine—kidney cancer	4.6e-05	0.00023	CcSEcCtD
Rabeprazole—Feeling abnormal—Paclitaxel—kidney cancer	4.58e-05	0.000229	CcSEcCtD
Rabeprazole—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.57e-05	0.000228	CcSEcCtD
Rabeprazole—Oedema—Capecitabine—kidney cancer	4.56e-05	0.000228	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Paclitaxel—kidney cancer	4.54e-05	0.000227	CcSEcCtD
Rabeprazole—Diarrhoea—Gemcitabine—kidney cancer	4.54e-05	0.000227	CcSEcCtD
Rabeprazole—Neuropathy peripheral—Doxorubicin—kidney cancer	4.52e-05	0.000226	CcSEcCtD
Rabeprazole—Jaundice—Doxorubicin—kidney cancer	4.49e-05	0.000224	CcSEcCtD
Rabeprazole—Stomatitis—Doxorubicin—kidney cancer	4.49e-05	0.000224	CcSEcCtD
Rabeprazole—Shock—Capecitabine—kidney cancer	4.49e-05	0.000224	CcSEcCtD
Rabeprazole—Conjunctivitis—Doxorubicin—kidney cancer	4.48e-05	0.000224	CcSEcCtD
Rabeprazole—Urinary tract infection—Doxorubicin—kidney cancer	4.48e-05	0.000224	CcSEcCtD
Rabeprazole—Thrombocytopenia—Capecitabine—kidney cancer	4.47e-05	0.000223	CcSEcCtD
Rabeprazole—Tachycardia—Capecitabine—kidney cancer	4.45e-05	0.000222	CcSEcCtD
Rabeprazole—Vomiting—Vincristine—kidney cancer	4.45e-05	0.000222	CcSEcCtD
Rabeprazole—Sweating—Doxorubicin—kidney cancer	4.42e-05	0.000221	CcSEcCtD
Rabeprazole—Urticaria—Paclitaxel—kidney cancer	4.42e-05	0.000221	CcSEcCtD
Rabeprazole—Rash—Vincristine—kidney cancer	4.41e-05	0.00022	CcSEcCtD
Rabeprazole—Hyperhidrosis—Capecitabine—kidney cancer	4.41e-05	0.00022	CcSEcCtD
Rabeprazole—Dermatitis—Vincristine—kidney cancer	4.41e-05	0.00022	CcSEcCtD
Rabeprazole—Haematuria—Doxorubicin—kidney cancer	4.4e-05	0.00022	CcSEcCtD
Rabeprazole—Abdominal pain—Paclitaxel—kidney cancer	4.39e-05	0.000219	CcSEcCtD
Rabeprazole—Body temperature increased—Paclitaxel—kidney cancer	4.39e-05	0.000219	CcSEcCtD
Rabeprazole—Headache—Vincristine—kidney cancer	4.38e-05	0.000219	CcSEcCtD
Rabeprazole—Epistaxis—Doxorubicin—kidney cancer	4.35e-05	0.000217	CcSEcCtD
Rabeprazole—Anorexia—Capecitabine—kidney cancer	4.35e-05	0.000217	CcSEcCtD
Rabeprazole—Sinusitis—Doxorubicin—kidney cancer	4.32e-05	0.000216	CcSEcCtD
Rabeprazole—Agranulocytosis—Doxorubicin—kidney cancer	4.3e-05	0.000215	CcSEcCtD
Rabeprazole—Hypotension—Capecitabine—kidney cancer	4.26e-05	0.000213	CcSEcCtD
Rabeprazole—Vomiting—Gemcitabine—kidney cancer	4.22e-05	0.000211	CcSEcCtD
Rabeprazole—Bradycardia—Doxorubicin—kidney cancer	4.21e-05	0.00021	CcSEcCtD
Rabeprazole—Rash—Gemcitabine—kidney cancer	4.19e-05	0.000209	CcSEcCtD
Rabeprazole—Dermatitis—Gemcitabine—kidney cancer	4.18e-05	0.000209	CcSEcCtD
Rabeprazole—Headache—Gemcitabine—kidney cancer	4.16e-05	0.000208	CcSEcCtD
Rabeprazole—Nausea—Vincristine—kidney cancer	4.16e-05	0.000208	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.16e-05	0.000208	CcSEcCtD
Rabeprazole—Rhinitis—Doxorubicin—kidney cancer	4.15e-05	0.000207	CcSEcCtD
Rabeprazole—Hepatitis—Doxorubicin—kidney cancer	4.14e-05	0.000207	CcSEcCtD
Rabeprazole—Insomnia—Capecitabine—kidney cancer	4.13e-05	0.000206	CcSEcCtD
Rabeprazole—Pharyngitis—Doxorubicin—kidney cancer	4.11e-05	0.000205	CcSEcCtD
Rabeprazole—Paraesthesia—Capecitabine—kidney cancer	4.1e-05	0.000205	CcSEcCtD
Rabeprazole—Hypersensitivity—Paclitaxel—kidney cancer	4.09e-05	0.000205	CcSEcCtD
Rabeprazole—Urinary tract disorder—Doxorubicin—kidney cancer	4.09e-05	0.000204	CcSEcCtD
Rabeprazole—Oedema peripheral—Doxorubicin—kidney cancer	4.08e-05	0.000204	CcSEcCtD
Rabeprazole—Dyspnoea—Capecitabine—kidney cancer	4.07e-05	0.000203	CcSEcCtD
Rabeprazole—Urethral disorder—Doxorubicin—kidney cancer	4.06e-05	0.000203	CcSEcCtD
Rabeprazole—Dyspepsia—Capecitabine—kidney cancer	4.01e-05	0.000201	CcSEcCtD
Rabeprazole—Visual impairment—Doxorubicin—kidney cancer	3.99e-05	0.000199	CcSEcCtD
Rabeprazole—Asthenia—Paclitaxel—kidney cancer	3.99e-05	0.000199	CcSEcCtD
Rabeprazole—Decreased appetite—Capecitabine—kidney cancer	3.96e-05	0.000198	CcSEcCtD
Rabeprazole—Nausea—Gemcitabine—kidney cancer	3.94e-05	0.000197	CcSEcCtD
Rabeprazole—Pruritus—Paclitaxel—kidney cancer	3.93e-05	0.000196	CcSEcCtD
Rabeprazole—Erythema multiforme—Doxorubicin—kidney cancer	3.91e-05	0.000195	CcSEcCtD
Rabeprazole—Constipation—Capecitabine—kidney cancer	3.9e-05	0.000195	CcSEcCtD
Rabeprazole—Pain—Capecitabine—kidney cancer	3.9e-05	0.000195	CcSEcCtD
Rabeprazole—Eye disorder—Doxorubicin—kidney cancer	3.87e-05	0.000193	CcSEcCtD
Rabeprazole—Tinnitus—Doxorubicin—kidney cancer	3.86e-05	0.000193	CcSEcCtD
Rabeprazole—Diarrhoea—Paclitaxel—kidney cancer	3.8e-05	0.00019	CcSEcCtD
Rabeprazole—Feeling abnormal—Capecitabine—kidney cancer	3.76e-05	0.000188	CcSEcCtD
Rabeprazole—Angiopathy—Doxorubicin—kidney cancer	3.75e-05	0.000188	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Capecitabine—kidney cancer	3.73e-05	0.000186	CcSEcCtD
Rabeprazole—Chills—Doxorubicin—kidney cancer	3.71e-05	0.000185	CcSEcCtD
Rabeprazole—Arrhythmia—Doxorubicin—kidney cancer	3.7e-05	0.000185	CcSEcCtD
Rabeprazole—Dizziness—Paclitaxel—kidney cancer	3.68e-05	0.000184	CcSEcCtD
Rabeprazole—Alopecia—Doxorubicin—kidney cancer	3.66e-05	0.000183	CcSEcCtD
Rabeprazole—Urticaria—Capecitabine—kidney cancer	3.62e-05	0.000181	CcSEcCtD
Rabeprazole—Body temperature increased—Capecitabine—kidney cancer	3.61e-05	0.00018	CcSEcCtD
Rabeprazole—Abdominal pain—Capecitabine—kidney cancer	3.61e-05	0.00018	CcSEcCtD
Rabeprazole—Malnutrition—Doxorubicin—kidney cancer	3.6e-05	0.00018	CcSEcCtD
Rabeprazole—Erythema—Doxorubicin—kidney cancer	3.6e-05	0.00018	CcSEcCtD
Rabeprazole—Flatulence—Doxorubicin—kidney cancer	3.55e-05	0.000177	CcSEcCtD
Rabeprazole—Tension—Doxorubicin—kidney cancer	3.54e-05	0.000177	CcSEcCtD
Rabeprazole—Vomiting—Paclitaxel—kidney cancer	3.53e-05	0.000177	CcSEcCtD
Rabeprazole—Dysgeusia—Doxorubicin—kidney cancer	3.53e-05	0.000176	CcSEcCtD
Rabeprazole—Rash—Paclitaxel—kidney cancer	3.5e-05	0.000175	CcSEcCtD
Rabeprazole—Dermatitis—Paclitaxel—kidney cancer	3.5e-05	0.000175	CcSEcCtD
Rabeprazole—Nervousness—Doxorubicin—kidney cancer	3.5e-05	0.000175	CcSEcCtD
Rabeprazole—Back pain—Doxorubicin—kidney cancer	3.48e-05	0.000174	CcSEcCtD
Rabeprazole—Headache—Paclitaxel—kidney cancer	3.48e-05	0.000174	CcSEcCtD
Rabeprazole—Muscle spasms—Doxorubicin—kidney cancer	3.46e-05	0.000173	CcSEcCtD
Rabeprazole—Vision blurred—Doxorubicin—kidney cancer	3.4e-05	0.00017	CcSEcCtD
Rabeprazole—Hypersensitivity—Capecitabine—kidney cancer	3.36e-05	0.000168	CcSEcCtD
Rabeprazole—Ill-defined disorder—Doxorubicin—kidney cancer	3.34e-05	0.000167	CcSEcCtD
Rabeprazole—Anaemia—Doxorubicin—kidney cancer	3.33e-05	0.000166	CcSEcCtD
Rabeprazole—Agitation—Doxorubicin—kidney cancer	3.31e-05	0.000165	CcSEcCtD
Rabeprazole—Nausea—Paclitaxel—kidney cancer	3.3e-05	0.000165	CcSEcCtD
Rabeprazole—Asthenia—Capecitabine—kidney cancer	3.27e-05	0.000163	CcSEcCtD
Rabeprazole—Malaise—Doxorubicin—kidney cancer	3.25e-05	0.000162	CcSEcCtD
Rabeprazole—Vertigo—Doxorubicin—kidney cancer	3.24e-05	0.000162	CcSEcCtD
Rabeprazole—Syncope—Doxorubicin—kidney cancer	3.23e-05	0.000161	CcSEcCtD
Rabeprazole—Pruritus—Capecitabine—kidney cancer	3.23e-05	0.000161	CcSEcCtD
Rabeprazole—Leukopenia—Doxorubicin—kidney cancer	3.22e-05	0.000161	CcSEcCtD
Rabeprazole—Palpitations—Doxorubicin—kidney cancer	3.18e-05	0.000159	CcSEcCtD
Rabeprazole—Loss of consciousness—Doxorubicin—kidney cancer	3.17e-05	0.000158	CcSEcCtD
Rabeprazole—Cough—Doxorubicin—kidney cancer	3.14e-05	0.000157	CcSEcCtD
Rabeprazole—Convulsion—Doxorubicin—kidney cancer	3.12e-05	0.000156	CcSEcCtD
Rabeprazole—Diarrhoea—Capecitabine—kidney cancer	3.12e-05	0.000156	CcSEcCtD
Rabeprazole—Hypertension—Doxorubicin—kidney cancer	3.11e-05	0.000155	CcSEcCtD
Rabeprazole—Myalgia—Doxorubicin—kidney cancer	3.07e-05	0.000153	CcSEcCtD
Rabeprazole—Arthralgia—Doxorubicin—kidney cancer	3.07e-05	0.000153	CcSEcCtD
Rabeprazole—Chest pain—Doxorubicin—kidney cancer	3.07e-05	0.000153	CcSEcCtD
Rabeprazole—Anxiety—Doxorubicin—kidney cancer	3.06e-05	0.000153	CcSEcCtD
Rabeprazole—Discomfort—Doxorubicin—kidney cancer	3.03e-05	0.000151	CcSEcCtD
Rabeprazole—Dizziness—Capecitabine—kidney cancer	3.02e-05	0.000151	CcSEcCtD
Rabeprazole—Dry mouth—Doxorubicin—kidney cancer	3e-05	0.00015	CcSEcCtD
Rabeprazole—Confusional state—Doxorubicin—kidney cancer	2.96e-05	0.000148	CcSEcCtD
Rabeprazole—Oedema—Doxorubicin—kidney cancer	2.94e-05	0.000147	CcSEcCtD
Rabeprazole—Anaphylactic shock—Doxorubicin—kidney cancer	2.94e-05	0.000147	CcSEcCtD
Rabeprazole—Vomiting—Capecitabine—kidney cancer	2.9e-05	0.000145	CcSEcCtD
Rabeprazole—Shock—Doxorubicin—kidney cancer	2.89e-05	0.000144	CcSEcCtD
Rabeprazole—Thrombocytopenia—Doxorubicin—kidney cancer	2.88e-05	0.000144	CcSEcCtD
Rabeprazole—Rash—Capecitabine—kidney cancer	2.88e-05	0.000144	CcSEcCtD
Rabeprazole—Dermatitis—Capecitabine—kidney cancer	2.87e-05	0.000144	CcSEcCtD
Rabeprazole—Tachycardia—Doxorubicin—kidney cancer	2.87e-05	0.000143	CcSEcCtD
Rabeprazole—Headache—Capecitabine—kidney cancer	2.86e-05	0.000143	CcSEcCtD
Rabeprazole—Hyperhidrosis—Doxorubicin—kidney cancer	2.84e-05	0.000142	CcSEcCtD
Rabeprazole—Anorexia—Doxorubicin—kidney cancer	2.8e-05	0.00014	CcSEcCtD
Rabeprazole—Hypotension—Doxorubicin—kidney cancer	2.75e-05	0.000137	CcSEcCtD
Rabeprazole—Nausea—Capecitabine—kidney cancer	2.71e-05	0.000135	CcSEcCtD
Rabeprazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.68e-05	0.000134	CcSEcCtD
Rabeprazole—Insomnia—Doxorubicin—kidney cancer	2.66e-05	0.000133	CcSEcCtD
Rabeprazole—Paraesthesia—Doxorubicin—kidney cancer	2.64e-05	0.000132	CcSEcCtD
Rabeprazole—Dyspnoea—Doxorubicin—kidney cancer	2.62e-05	0.000131	CcSEcCtD
Rabeprazole—Somnolence—Doxorubicin—kidney cancer	2.61e-05	0.000131	CcSEcCtD
Rabeprazole—Dyspepsia—Doxorubicin—kidney cancer	2.59e-05	0.000129	CcSEcCtD
Rabeprazole—Decreased appetite—Doxorubicin—kidney cancer	2.56e-05	0.000128	CcSEcCtD
Rabeprazole—Constipation—Doxorubicin—kidney cancer	2.51e-05	0.000126	CcSEcCtD
Rabeprazole—Pain—Doxorubicin—kidney cancer	2.51e-05	0.000126	CcSEcCtD
Rabeprazole—Feeling abnormal—Doxorubicin—kidney cancer	2.42e-05	0.000121	CcSEcCtD
Rabeprazole—Gastrointestinal pain—Doxorubicin—kidney cancer	2.4e-05	0.00012	CcSEcCtD
Rabeprazole—Urticaria—Doxorubicin—kidney cancer	2.34e-05	0.000117	CcSEcCtD
Rabeprazole—Body temperature increased—Doxorubicin—kidney cancer	2.32e-05	0.000116	CcSEcCtD
Rabeprazole—Abdominal pain—Doxorubicin—kidney cancer	2.32e-05	0.000116	CcSEcCtD
Rabeprazole—Hypersensitivity—Doxorubicin—kidney cancer	2.17e-05	0.000108	CcSEcCtD
Rabeprazole—Asthenia—Doxorubicin—kidney cancer	2.11e-05	0.000105	CcSEcCtD
Rabeprazole—Pruritus—Doxorubicin—kidney cancer	2.08e-05	0.000104	CcSEcCtD
Rabeprazole—Diarrhoea—Doxorubicin—kidney cancer	2.01e-05	0.0001	CcSEcCtD
Rabeprazole—Dizziness—Doxorubicin—kidney cancer	1.94e-05	9.71e-05	CcSEcCtD
Rabeprazole—Vomiting—Doxorubicin—kidney cancer	1.87e-05	9.34e-05	CcSEcCtD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.86e-05	0.000448	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PDHB—kidney cancer	1.86e-05	0.000447	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.85e-05	0.000446	CbGpPWpGaD
Rabeprazole—Rash—Doxorubicin—kidney cancer	1.85e-05	9.26e-05	CcSEcCtD
Rabeprazole—Dermatitis—Doxorubicin—kidney cancer	1.85e-05	9.25e-05	CcSEcCtD
Rabeprazole—CYP2C9—Biological oxidations—POMC—kidney cancer	1.85e-05	0.000445	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.84e-05	0.000444	CbGpPWpGaD
Rabeprazole—Headache—Doxorubicin—kidney cancer	1.84e-05	9.2e-05	CcSEcCtD
Rabeprazole—CYP1A1—Metabolism—GPC3—kidney cancer	1.77e-05	0.000427	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CCBL1—kidney cancer	1.76e-05	0.000424	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CCBL1—kidney cancer	1.75e-05	0.00042	CbGpPWpGaD
Rabeprazole—Nausea—Doxorubicin—kidney cancer	1.75e-05	8.72e-05	CcSEcCtD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.73e-05	0.000417	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.73e-05	0.000416	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CA2—kidney cancer	1.73e-05	0.000415	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.7e-05	0.00041	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALAD—kidney cancer	1.68e-05	0.000404	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GLIPR1—kidney cancer	1.66e-05	0.000399	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PPAT—kidney cancer	1.66e-05	0.000399	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CRABP1—kidney cancer	1.64e-05	0.000395	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ST3GAL2—kidney cancer	1.64e-05	0.000395	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.64e-05	0.000394	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.64e-05	0.000394	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.62e-05	0.00039	CbGpPWpGaD
Rabeprazole—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.62e-05	0.000389	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ALDH1A1—kidney cancer	1.6e-05	0.000386	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.59e-05	0.000383	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PDHB—kidney cancer	1.59e-05	0.000382	CbGpPWpGaD
Rabeprazole—CYP1A2—Biological oxidations—POMC—kidney cancer	1.58e-05	0.000381	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.58e-05	0.00038	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—APRT—kidney cancer	1.54e-05	0.000371	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—FH—kidney cancer	1.54e-05	0.000371	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PGK1—kidney cancer	1.54e-05	0.00037	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SLC5A3—kidney cancer	1.54e-05	0.00037	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GLIPR1—kidney cancer	1.53e-05	0.000367	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PPAT—kidney cancer	1.53e-05	0.000367	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ITPR2—kidney cancer	1.53e-05	0.000367	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GLIPR1—kidney cancer	1.51e-05	0.000364	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PPAT—kidney cancer	1.51e-05	0.000364	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.51e-05	0.000363	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—LDHB—kidney cancer	1.51e-05	0.000363	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.5e-05	0.00036	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CCBL1—kidney cancer	1.49e-05	0.000359	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.48e-05	0.000356	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GPC3—kidney cancer	1.45e-05	0.000349	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ACY1—kidney cancer	1.44e-05	0.000347	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—FH—kidney cancer	1.42e-05	0.000342	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—APRT—kidney cancer	1.42e-05	0.000342	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CA2—kidney cancer	1.41e-05	0.00034	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—APRT—kidney cancer	1.41e-05	0.000339	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—FH—kidney cancer	1.41e-05	0.000339	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ACHE—kidney cancer	1.39e-05	0.000335	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTT1—kidney cancer	1.39e-05	0.000335	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALAD—kidney cancer	1.38e-05	0.000331	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.38e-05	0.000331	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.35e-05	0.000325	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ST3GAL2—kidney cancer	1.34e-05	0.000323	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GPC3—kidney cancer	1.34e-05	0.000321	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GPC3—kidney cancer	1.32e-05	0.000318	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SCARB1—kidney cancer	1.32e-05	0.000317	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ALDH1A1—kidney cancer	1.31e-05	0.000316	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CA9—kidney cancer	1.31e-05	0.000315	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS1—kidney cancer	1.31e-05	0.000314	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CA2—kidney cancer	1.3e-05	0.000312	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.29e-05	0.000311	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PPAT—kidney cancer	1.29e-05	0.000311	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CA2—kidney cancer	1.29e-05	0.00031	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PSMD7—kidney cancer	1.28e-05	0.000308	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.28e-05	0.000307	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALAD—kidney cancer	1.27e-05	0.000304	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.26e-05	0.000304	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PGK1—kidney cancer	1.26e-05	0.000303	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC5A3—kidney cancer	1.26e-05	0.000303	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALAD—kidney cancer	1.25e-05	0.000302	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.24e-05	0.000297	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—LDHB—kidney cancer	1.23e-05	0.000297	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PDHB—kidney cancer	1.23e-05	0.000295	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.22e-05	0.000295	CbGpPWpGaD
Rabeprazole—CYP3A4—Biological oxidations—POMC—kidney cancer	1.22e-05	0.000294	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—BCHE—kidney cancer	1.21e-05	0.000292	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.21e-05	0.00029	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—FH—kidney cancer	1.2e-05	0.000289	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—APRT—kidney cancer	1.2e-05	0.000289	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SLC5A5—kidney cancer	1.2e-05	0.000288	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.2e-05	0.000288	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.18e-05	0.000283	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PGK1—kidney cancer	1.16e-05	0.000278	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.16e-05	0.000278	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—SLC2A1—kidney cancer	1.16e-05	0.000278	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CCBL1—kidney cancer	1.15e-05	0.000277	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.15e-05	0.000276	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PGK1—kidney cancer	1.15e-05	0.000276	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—LDHB—kidney cancer	1.14e-05	0.000273	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GPC3—kidney cancer	1.13e-05	0.000272	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—LDHB—kidney cancer	1.13e-05	0.000271	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—CRABP1—kidney cancer	1.11e-05	0.000267	CbGpPWpGaD
Rabeprazole—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.1e-05	0.000265	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CA2—kidney cancer	1.1e-05	0.000265	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALAD—kidney cancer	1.07e-05	0.000258	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CA9—kidney cancer	1.07e-05	0.000257	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.05e-05	0.000252	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.05e-05	0.000252	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ITPR2—kidney cancer	1.03e-05	0.000249	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.02e-05	0.000246	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GLIPR1—kidney cancer	9.99e-06	0.00024	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PPAT—kidney cancer	9.99e-06	0.00024	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CA9—kidney cancer	9.84e-06	0.000237	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC5A3—kidney cancer	9.81e-06	0.000236	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PGK1—kidney cancer	9.81e-06	0.000236	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CA9—kidney cancer	9.76e-06	0.000235	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTP1—kidney cancer	9.65e-06	0.000232	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—LDHB—kidney cancer	9.62e-06	0.000231	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.54e-06	0.000229	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.53e-06	0.000229	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTT1—kidney cancer	9.43e-06	0.000227	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ACHE—kidney cancer	9.43e-06	0.000227	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—APRT—kidney cancer	9.28e-06	0.000223	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—FH—kidney cancer	9.28e-06	0.000223	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—ABCB1—kidney cancer	9.14e-06	0.00022	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CRABP1—kidney cancer	9.1e-06	0.000219	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SCARB1—kidney cancer	8.92e-06	0.000215	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—GSTM1—kidney cancer	8.87e-06	0.000213	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS1—kidney cancer	8.83e-06	0.000212	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GPC3—kidney cancer	8.73e-06	0.00021	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PSMD7—kidney cancer	8.66e-06	0.000208	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA2—kidney cancer	8.49e-06	0.000204	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ITPR2—kidney cancer	8.46e-06	0.000203	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—CYP1A1—kidney cancer	8.41e-06	0.000202	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CRABP1—kidney cancer	8.37e-06	0.000201	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CA9—kidney cancer	8.34e-06	0.000201	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CRABP1—kidney cancer	8.3e-06	0.0002	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALAD—kidney cancer	8.28e-06	0.000199	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—BCHE—kidney cancer	8.21e-06	0.000198	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.15e-06	0.000196	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SLC5A5—kidney cancer	8.11e-06	0.000195	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.08e-06	0.000194	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.89e-06	0.00019	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—SLC2A1—kidney cancer	7.83e-06	0.000188	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.8e-06	0.000188	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ITPR2—kidney cancer	7.78e-06	0.000187	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ACHE—kidney cancer	7.71e-06	0.000186	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTT1—kidney cancer	7.71e-06	0.000186	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ITPR2—kidney cancer	7.71e-06	0.000186	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.6e-06	0.000183	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PGK1—kidney cancer	7.57e-06	0.000182	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.57e-06	0.000182	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—LDHB—kidney cancer	7.42e-06	0.000179	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SCARB1—kidney cancer	7.3e-06	0.000176	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS1—kidney cancer	7.23e-06	0.000174	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.11e-06	0.000171	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ACHE—kidney cancer	7.1e-06	0.000171	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTT1—kidney cancer	7.1e-06	0.000171	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CRABP1—kidney cancer	7.09e-06	0.000171	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PSMD7—kidney cancer	7.09e-06	0.000171	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ACHE—kidney cancer	7.03e-06	0.000169	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTT1—kidney cancer	7.03e-06	0.000169	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—BCHE—kidney cancer	6.72e-06	0.000162	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SCARB1—kidney cancer	6.72e-06	0.000162	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SCARB1—kidney cancer	6.66e-06	0.00016	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS1—kidney cancer	6.65e-06	0.00016	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC5A5—kidney cancer	6.64e-06	0.00016	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.63e-06	0.000159	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ITPR2—kidney cancer	6.59e-06	0.000159	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS1—kidney cancer	6.59e-06	0.000159	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTP1—kidney cancer	6.53e-06	0.000157	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PSMD7—kidney cancer	6.52e-06	0.000157	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PSMD7—kidney cancer	6.46e-06	0.000155	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CA9—kidney cancer	6.44e-06	0.000155	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—SLC2A1—kidney cancer	6.41e-06	0.000154	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—POMC—kidney cancer	6.27e-06	0.000151	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.22e-06	0.00015	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—ABCB1—kidney cancer	6.19e-06	0.000149	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—BCHE—kidney cancer	6.18e-06	0.000149	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—BCHE—kidney cancer	6.13e-06	0.000147	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC5A5—kidney cancer	6.11e-06	0.000147	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.08e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC5A5—kidney cancer	6.05e-06	0.000146	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTT1—kidney cancer	6.01e-06	0.000145	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ACHE—kidney cancer	6.01e-06	0.000145	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—GSTM1—kidney cancer	6e-06	0.000144	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—SLC2A1—kidney cancer	5.9e-06	0.000142	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.85e-06	0.000141	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SCARB1—kidney cancer	5.69e-06	0.000137	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.67e-06	0.000136	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS1—kidney cancer	5.63e-06	0.000135	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PSMD7—kidney cancer	5.52e-06	0.000133	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CRABP1—kidney cancer	5.47e-06	0.000132	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.42e-06	0.00013	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTP1—kidney cancer	5.35e-06	0.000129	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—BCHE—kidney cancer	5.24e-06	0.000126	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC5A5—kidney cancer	5.17e-06	0.000124	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ITPR2—kidney cancer	5.09e-06	0.000122	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—ABCB1—kidney cancer	5.06e-06	0.000122	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTGS2—kidney cancer	5e-06	0.00012	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—SLC2A1—kidney cancer	5e-06	0.00012	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.95e-06	0.000119	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTP1—kidney cancer	4.92e-06	0.000118	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—GSTM1—kidney cancer	4.91e-06	0.000118	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTP1—kidney cancer	4.88e-06	0.000117	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.85e-06	0.000117	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.68e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—CYP1A1—kidney cancer	4.66e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—ABCB1—kidney cancer	4.66e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTT1—kidney cancer	4.64e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ACHE—kidney cancer	4.64e-06	0.000112	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—ABCB1—kidney cancer	4.62e-06	0.000111	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—GSTM1—kidney cancer	4.52e-06	0.000109	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—GSTM1—kidney cancer	4.48e-06	0.000108	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SCARB1—kidney cancer	4.39e-06	0.000106	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PTEN—kidney cancer	4.36e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS1—kidney cancer	4.35e-06	0.000105	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.28e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PSMD7—kidney cancer	4.26e-06	0.000103	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.25e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—POMC—kidney cancer	4.24e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.23e-06	0.000102	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTP1—kidney cancer	4.17e-06	0.0001	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—BCHE—kidney cancer	4.04e-06	9.72e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.99e-06	9.6e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—ABCB1—kidney cancer	3.94e-06	9.49e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.86e-06	9.27e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—GSTM1—kidney cancer	3.83e-06	9.21e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.83e-06	9.2e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.63e-06	8.73e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.49e-06	8.39e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—POMC—kidney cancer	3.47e-06	8.35e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTGS2—kidney cancer	3.39e-06	8.14e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTP1—kidney cancer	3.22e-06	7.73e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—POMC—kidney cancer	3.19e-06	7.68e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—POMC—kidney cancer	3.17e-06	7.62e-05	CbGpPWpGaD
Rabeprazole—ABCG2—Metabolism—PIK3CA—kidney cancer	3.08e-06	7.4e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—ABCB1—kidney cancer	3.04e-06	7.32e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.98e-06	7.17e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—GSTM1—kidney cancer	2.95e-06	7.11e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PTEN—kidney cancer	2.95e-06	7.1e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.8e-06	6.74e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTGS2—kidney cancer	2.77e-06	6.66e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—POMC—kidney cancer	2.71e-06	6.51e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTGS2—kidney cancer	2.55e-06	6.13e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTGS2—kidney cancer	2.53e-06	6.08e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PTEN—kidney cancer	2.42e-06	5.81e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PTEN—kidney cancer	2.22e-06	5.34e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PTEN—kidney cancer	2.2e-06	5.3e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTGS2—kidney cancer	2.16e-06	5.19e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—POMC—kidney cancer	2.09e-06	5.02e-05	CbGpPWpGaD
Rabeprazole—CYP1A1—Metabolism—PIK3CA—kidney cancer	2.08e-06	5.01e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PTEN—kidney cancer	1.88e-06	4.53e-05	CbGpPWpGaD
Rabeprazole—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.7e-06	4.1e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTGS2—kidney cancer	1.67e-06	4.01e-05	CbGpPWpGaD
Rabeprazole—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.57e-06	3.77e-05	CbGpPWpGaD
Rabeprazole—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.55e-06	3.74e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PTEN—kidney cancer	1.45e-06	3.49e-05	CbGpPWpGaD
Rabeprazole—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.33e-06	3.19e-05	CbGpPWpGaD
Rabeprazole—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.02e-06	2.47e-05	CbGpPWpGaD
